Pfizer has withdrawn an application for emergency-use authorisation of its Covid vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday.
The company had a meeting with India’s drugs regulator on Wednesday and the decision was made after that, the company said.
“Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” it said in a statement, adding it will in the future look to resubmit its application with the additional information that the regulator requires.
India’s COVID-19 tally of cases rose to 1,08,02,591 with 12,408 new infections being reported in a day, while the recoveries surged to 1,04,96,308, according to the Union Health Ministry data updated on Friday.
The death count increased to 1,54,823 with 120 daily new fatalities, the data showed.
